Tumores colorrectales
Desarrollo y puesta en marcha de una estrategia de medicina personalizada en pacientes con cáncer colorectal.
Grupo consolidado en el manejo de pacientes con cáncer colorectal que reúne y coordina en un equipo multidisciplinar toda la investigación básica, clínica y traslacional realizada en la Clínica Universidad de Navarra y en el Centro para la Investigación Médica Aplicada (CIMA) en torno al desarrollo e innovación terapeutica en el cáncer de colon.
Aparicio, B, Silva, L, Ruiz, M, Llópiz, D, Repáraz, D, Theunissen, P, Tamayo, I, Egea, J, Igea, A, Smerdou, C, Peñas, M, Perpiñá, C, Matilla, A, Varela, M, Reig, M, de la Torre-alaez, M, Argemí, J, Sangro, B, Hervás-Stubbs, S, Sarobe, P
"Immunogenicity of neoantigens from hepatocellular carcinoma patients treated with a combined radioimmunotherapy".
OncoImmunology. 15(1): 2645280. 2026. [doi:10.1080/2162402X.2026.2645280]
Molina, A, Trigueros-Motos, L, Molina, M, Martínez-García, J, Palomo, L, Pérez, G, Odriozola, L, Gázquez, C, Tamarit, B, Van Faassen, M, Verkade, HJ, Bouquet, C, Combal, JP, González-Aseguinolaza, G, Smerdou, C
"Liver-directed gene therapy results in amelioration of progressive familial intrahepatic cholestasis type 2 in mice".
Hepatol. Commun.. 10(9): e1027. 2026. [doi:10.1097/HC9.0000000000001027]
Sangro, P, Landa-Magdalena, A, Sogbe, M, Zumarraga, T, Matos, I, Ponz-Sarvise, M, Crespo, M, Rodriguez-Ruiz, ME, Vilalta-Lacarra, A, Castañón, E
"Prognostic value of existing scoring systems for early mortality in phase I immunotherapy trials: a head-to-head real-world cohort study".
Front. Oncol.. 16: 1849425. 2026. [doi:10.3389/fonc.2026.1849425]
Amaya, E, Palma, J, Fayós-Solà, R, Meiriño, R, Cambeiro, M, Navarrete, A, Cabello-García, P, Viñals, A, Pedrero, D, Calvo, FA, Aristu, J, Serrano, J
"Salvage Proton Therapy Re-Irradiation in Recurrent Head and Neck Cancer: Outcomes and Adverse Events by Re-Irradiated Target Site".
Cancers. 18(14): 2207. 2026. [doi:10.3390/cancers18142207]
Cubillo, A, Lete, AL, Martin, AJM, Berger, MD, Ponz, M, Batko, S, John, S, Burkhart, N, Diaz, IA, Holecková, PB, Kueng, M, Melichar, B, Mercade, TM, Seufferlein, T
"PANOVA-4: Phase II study of tumor treating fields (TTFields) with atezolizumab and gemcitabine/nab-paclitaxel (GnP) for untreated metastatic pancreatic ductal adenocarcinoma (mPDAC)".
Ann. Oncol.. 37: 99 - 99. 2026. [doi:10.1016/j.annonc.2026.05.301]
Milella, M, Wasan, HS, Eccles, A, Garufi, C, Ventroni, G, Garcia-Carbonero, R, Adeva, JA, Cubero, JH, Castet, F, Ponce, CG, Vázquez-Sequeiros, E, Martín, AJM, Hubner, R, Maher, B, Ponz, M, Pandanaboyana, S, Bouderez, V, Nguyen, NQ, Martel, IJ, Malleo, G
"TRIPP-FFX: An open-label, multi-centre, randomized study of TaRgeted Intratumoural placement of phosphorous-32 microparticles added to FOLFIRINOX (FFX) versus FFX alone in patients with unresectable locally advanced pancreatic cancer (uLAPC)".
Ann. Oncol.. 37: 121 - 121. 2026. [doi:10.1016/j.annonc.2026.06.011]
Izquierdo-Sanchez, L, Lete, AL, Erdmann, J, Lacasta, A, Valsan, A, Roessler, S, Braconi, C, Da Fonseca, LG, Dopazo, C, Folseraas, T, Koerkamp, BG, Balderramo, D, Ponz, M, Ferrer, JD, Zieniewicz, K, Utpatel, K, Sparchez, ZA, Brustia, R, Forner, A, Asurmendi, JMB
"Cholangiocarcinoma in individuals with chronic liver disease is diagnosed earlier leading to better prognosis: Evidence from the International BTC Registry".
Ann. Oncol.. 37: 133 - 133. 2026. [doi:10.1016/j.annonc.2026.05.397]
Dziadziuszko, R, Garcia, VM, Lugowska, I, Rojas, CI, Garcia, IM, Dizdar, O, Xue, J, Gottfried, M, Rottenberg, Y, Simonelli, M, Kwiatkowski, M, Sendur, MAN, Ursol, G, Kobziev, O, Lin, CC, Jemielita, T, Ayers, M, Choi, SY, Garrido, M
"Calderasib (MK-1084) for KRAS G12C-mutated (mut) advanced colorectal cancer (CRC): Results from KANDLELIT-001".
Ann. Oncol.. 37: 6 - 6. 2026. [doi:10.1016/j.annonc.2026.05.010]
Paredes, LC, Mercade, TM, Lete, AL, Goldaraz, FG, Llarena, AM, Seoane, P, Magdalena, AL, Ortega, AC, Ponz, M
"Safety and efficacy and the impact on liver metastases microenviroment of tumor treating fields in combination with mFOLFIRINOX in pancreatic cancer".
Ann. Oncol.. 37: 173 - 173. 2026. [doi:10.1016/j.annonc.2026.05.513]
Arredondo, J, Aliseda, D, Castañón, C, Pastor, E, Tejedor, P, Muinelo, M, Pastor, C, Flórez, LG, Vigorita, V, Gallarin, I, Montoya, M, Tasende, M, Garcia, F, Rodriguez, P, de la Hermosa, AR, Simó, V, Alvarez, C, Rodriguez, C, Núñez-Córdoba, JM, Rodriguez, J
"ELECLA trial: final results of perioperative chemotherapy with fluoropyrimidine and oxaliplatin in mismatch repair proficient locally advanced colon cancer".
ESMO Open. 11(7): 108250. 2026. [doi:10.1016/j.esmoop.2026.108250]
|